Nymox Pharmaceutical OTC Stock Forecast - Naive Prediction

NYMXF Stock   0.05  0.01  8.93%   
The Naive Prediction forecasted value of Nymox Pharmaceutical on the next trading day is expected to be 0.06 with a mean absolute deviation of 0.01 and the sum of the absolute errors of 0.49. Investors can use prediction functions to forecast Nymox Pharmaceutical's stock prices and determine the direction of Nymox Pharmaceutical's future trends based on various well-known forecasting models. However, exclusively looking at the historical price movement is usually misleading. We recommend always using this module together with an analysis of Nymox Pharmaceutical's historical fundamentals, such as revenue growth or operating cash flow patterns. Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be closely tied with the direction of predictive economic indicators such as various price indices. As of 26th of January 2026, the value of RSI of Nymox Pharmaceutical's share price is approaching 44. This indicates that the otc stock is in nutural position, most likellhy at or near its support level. The main point of RSI analysis is to track how fast people are buying or selling Nymox Pharmaceutical, making its price go up or down.

Momentum 44

 Sell Extended

 
Oversold
 
Overbought
Nymox Pharmaceutical stock price prediction is an act of determining the future value of Nymox Pharmaceutical shares using few different conventional methods such as EPS estimation, analyst consensus, or fundamental intrinsic valuation. The successful prediction of Nymox Pharmaceutical's future price could yield a significant profit. Please, note that this module is not intended to be used solely to calculate an intrinsic value of Nymox Pharmaceutical and does not consider all of the tangible or intangible factors available from Nymox Pharmaceutical's fundamental data. We analyze noise-free headlines and recent hype associated with Nymox Pharmaceutical, which may create opportunities for some arbitrage if properly timed.
It is a matter of debate whether otc price prediction based on information in financial news can generate a strong buy or sell signal. We use our internally-built news screening methodology to estimate the value of Nymox Pharmaceutical based on different types of headlines from major news networks to social media. Using Nymox Pharmaceutical hype-based prediction, you can estimate the value of Nymox Pharmaceutical from the perspective of Nymox Pharmaceutical response to recently generated media hype and the effects of current headlines on its competitors.
The Naive Prediction forecasted value of Nymox Pharmaceutical on the next trading day is expected to be 0.06 with a mean absolute deviation of 0.01 and the sum of the absolute errors of 0.49.

Nymox Pharmaceutical after-hype prediction price

    
  USD 0.05  
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as otc price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
  
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be closely tied with the direction of predictive economic indicators such as various price indices.

Nymox Pharmaceutical Additional Predictive Modules

Most predictive techniques to examine Nymox price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Nymox using various technical indicators. When you analyze Nymox charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
A naive forecasting model for Nymox Pharmaceutical is a special case of the moving average forecasting where the number of periods used for smoothing is one. Therefore, the forecast of Nymox Pharmaceutical value for a given trading day is simply the observed value for the previous period. Due to the simplistic nature of the naive forecasting model, it can only be used to forecast up to one period.

Nymox Pharmaceutical Naive Prediction Price Forecast For the 27th of January

Given 90 days horizon, the Naive Prediction forecasted value of Nymox Pharmaceutical on the next trading day is expected to be 0.06 with a mean absolute deviation of 0.01, mean absolute percentage error of 0.000095, and the sum of the absolute errors of 0.49.
Please note that although there have been many attempts to predict Nymox OTC Stock prices using its time series forecasting, we generally do not recommend using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Nymox Pharmaceutical's next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).

Nymox Pharmaceutical OTC Stock Forecast Pattern

Nymox Pharmaceutical Forecasted Value

In the context of forecasting Nymox Pharmaceutical's OTC Stock value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. Nymox Pharmaceutical's downside and upside margins for the forecasting period are 0.0005 and 13.92, respectively. We have considered Nymox Pharmaceutical's daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Market Value
0.05
0.0005
Downside
0.06
Expected Value
13.92
Upside

Model Predictive Factors

The below table displays some essential indicators generated by the model showing the Naive Prediction forecasting method's relative quality and the estimations of the prediction error of Nymox Pharmaceutical otc stock data series using in forecasting. Note that when a statistical model is used to represent Nymox Pharmaceutical otc stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.
AICAkaike Information Criteria108.8457
BiasArithmetic mean of the errors None
MADMean absolute deviation0.0081
MAPEMean absolute percentage error0.1259
SAESum of the absolute errors0.4924
This model is not at all useful as a medium-long range forecasting tool of Nymox Pharmaceutical. This model is simplistic and is included partly for completeness and partly because of its simplicity. It is unlikely that you'll want to use this model directly to predict Nymox Pharmaceutical. Instead, consider using either the moving average model or the more general weighted moving average model with a higher (i.e., greater than 1) number of periods, and possibly a different set of weights.

Predictive Modules for Nymox Pharmaceutical

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Nymox Pharmaceutical. Regardless of method or technology, however, to accurately forecast the otc stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the otc stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Nymox Pharmaceutical's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.

Nymox Pharmaceutical Estimiated After-Hype Price Volatility

As far as predicting the price of Nymox Pharmaceutical at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Nymox Pharmaceutical or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of OTC Stock prices, such as prices of Nymox Pharmaceutical, with the unreliable approximations that try to describe financial returns.
   Next price density   
       Expected price to next headline  

Nymox Pharmaceutical OTC Stock Price Outlook Analysis

Have you ever been surprised when a price of a OTC Stock such as Nymox Pharmaceutical is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Nymox Pharmaceutical backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the OTC price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Nymox Pharmaceutical, there might be something going there, and it might present an excellent short sale opportunity.
Expected ReturnPeriod VolatilityHype ElasticityRelated ElasticityNews DensityRelated DensityExpected Hype
  0.29 
13.87
 0.00  
  0.02 
0 Events / Month
3 Events / Month
Uncertain
Latest traded priceExpected after-news pricePotential return on next major newsAverage after-hype volatility
0.05
0.05
5.66 
0.00  
Notes

Nymox Pharmaceutical Hype Timeline

Nymox Pharmaceutical is now traded for 0.05. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.02. Nymox is anticipated to decline in value after the next headline, with the price expected to drop to 0.05. The average volatility of media hype impact on the company price is insignificant. The price reduction on the next news is expected to be -5.66%, whereas the daily expected return is now at -0.29%. The volatility of related hype on Nymox Pharmaceutical is about 22392.64%, with the expected price after the next announcement by competition of 0.07. Assuming the 90 days horizon the next anticipated press release will be uncertain.
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be closely tied with the direction of predictive economic indicators such as various price indices.

Nymox Pharmaceutical Related Hype Analysis

Having access to credible news sources related to Nymox Pharmaceutical's direct competition is more important than ever and may enhance your ability to predict Nymox Pharmaceutical's future price movements. Getting to know how Nymox Pharmaceutical's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Nymox Pharmaceutical may potentially react to the hype associated with one of its peers.
Hype
Elasticity
News
Density
Semi
Deviation
Information
Ratio
Potential
Upside
Value
At Risk
Maximum
Drawdown
HMTXFHemostemix 0.00 0 per month 4.05 (0.01) 9.87 (8.76) 41.09 
HOOKHookipa Pharma 0.01 5 per month 1.34  0.08  3.45 (3.30) 7.38 
DVHGFDevonian Health Group 0.00 0 per month 0.00  0.17  0.00  0.00  6,004 
LVCLFLiving Cell Technologies 0.00 0 per month 0.00  0.06  0.00  0.00  61.22 
IMUCImmunoCellular Therapeutics 0.00 0 per month 17.42  0.15  97.53 (37.50) 223.80 
SRBCFSirona Biochem Corp 0.62 23 per month 0.00  0.12  0.00  0.00  5,000 
INTIInhibitor Therapeutics(0.0006)6 per month 5.46  0.11  11.63 (12.00) 107.08 
OXBOFOxford BioDynamics Plc(0.02)6 per month 12.09  0  0.00 (36.36) 150.00 
ALRTFALR Technologies 0.00 0 per month 10.54  0.05  35.10 (17.49) 101.02 
VPHIFValeo Pharma 0.01 7 per month 0.00 (0.13) 0.00  0.00  66.67 

Other Forecasting Options for Nymox Pharmaceutical

For every potential investor in Nymox, whether a beginner or expert, Nymox Pharmaceutical's price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Nymox OTC Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Nymox. Basic forecasting techniques help filter out the noise by identifying Nymox Pharmaceutical's price trends.

Nymox Pharmaceutical Related Equities

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Nymox Pharmaceutical otc stock to make a market-neutral strategy. Peer analysis of Nymox Pharmaceutical could also be used in its relative valuation, which is a method of valuing Nymox Pharmaceutical by comparing valuation metrics with similar companies.
 Risk & Return  Correlation

Nymox Pharmaceutical Market Strength Events

Market strength indicators help investors to evaluate how Nymox Pharmaceutical otc stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Nymox Pharmaceutical shares will generate the highest return on investment. By undertsting and applying Nymox Pharmaceutical otc stock market strength indicators, traders can identify Nymox Pharmaceutical entry and exit signals to maximize returns.

Nymox Pharmaceutical Risk Indicators

The analysis of Nymox Pharmaceutical's basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Nymox Pharmaceutical's investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting nymox otc stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.

Story Coverage note for Nymox Pharmaceutical

The number of cover stories for Nymox Pharmaceutical depends on current market conditions and Nymox Pharmaceutical's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Nymox Pharmaceutical is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Nymox Pharmaceutical's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.

Other Macroaxis Stories

Our audience includes start-ups and big corporations as well as marketing, public relation firms, and advertising agencies, including technology and finance journalists. Our platform and its news and story outlet are popular among finance students, amateur traders, self-guided investors, entrepreneurs, retirees and baby boomers, academic researchers, financial advisers, as well as professional money managers - a very diverse and influential demographic landscape united by one goal - build optimal investment portfolios